TUBULAR NEPHROTOXICITY DURING LONG-TERM IFOSFAMIDE AND MESNA THERAPY

[1] ABELING N, 1987, P AN M AM SOC CLIN, V6, P48

[2] ANTMAN KH, 1985, CANCER TREAT REP, V69, P499

[3] THE DEVELOPMENT OF MESNA FOR REGIONAL DETOXIFICATION [J]. CANCER TREATMENT REVIEWS, 1983, 10 : 33 - &

[4] DEFRONZO RA, 1974, CANCER CHEMOTH REP 1, V58, P375

[5] MESNUM AS A PROTECTOR AGAINST KIDNEY AND BLADDER TOXICITY WITH HIGH-DOSE IFOSFAMIDE TREATMENT [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (02) : 81 - 84

[6] FOSSA SD, 1980, CANCER TREAT REP, V64, P1103

[7] GOREN MP, 1987, CANCER TREAT REP, V71, P127

[8] GOREN MP, 1987, CANCER RES, V47, P1457

[9] HACKE M, 1983, CLIN PHYSIOL BIOCH, V1, P17

[10] IFOSFAMIDE - AN ACTIVE-DRUG IN THE TREATMENT OF ADENOCARCINOMA OF THE PANCREAS [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (03) : 367 - 372

[1] ABELING N, 1987, P AN M AM SOC CLIN, V6, P48

[2] ANTMAN KH, 1985, CANCER TREAT REP, V69, P499

[3] THE DEVELOPMENT OF MESNA FOR REGIONAL DETOXIFICATION [J]. CANCER TREATMENT REVIEWS, 1983, 10 : 33 - &

[4] DEFRONZO RA, 1974, CANCER CHEMOTH REP 1, V58, P375

[5] MESNUM AS A PROTECTOR AGAINST KIDNEY AND BLADDER TOXICITY WITH HIGH-DOSE IFOSFAMIDE TREATMENT [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (02) : 81 - 84

[6] FOSSA SD, 1980, CANCER TREAT REP, V64, P1103

[7] GOREN MP, 1987, CANCER TREAT REP, V71, P127

[8] GOREN MP, 1987, CANCER RES, V47, P1457

[9] HACKE M, 1983, CLIN PHYSIOL BIOCH, V1, P17

[10] IFOSFAMIDE - AN ACTIVE-DRUG IN THE TREATMENT OF ADENOCARCINOMA OF THE PANCREAS [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (03) : 367 - 372